Work

A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.1584.1584

Authors: John Glaspy, Tom Tang, Dean Rutty, Xiaoqiang Yan, Igor Bondarenko, Dmitrii Krasnozhon

Institutions: University of California, Los Angeles, Evive Biotech (China), Dnipro State Medical University

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2578989554

FWCI: 0.322

Cites:

Cited by: 4

Related to: 10